Everyday Law · Court of Appeals for the D.C. Circuit
Jun 26, 2026
AI illustrationA healthcare company challenges Medicare's drug payment inclusion. Should they be allowed to?
Your callShould a company be allowed to challenge Medicare's drug payment rules?
TL;DR
- 1Ardelyx, Inc. challenges a government rule counting its drug XPHOZAH as part of Medicare's payment for kidney dialysis services.
- 2They say the rule is unfair because it forces oral-only drugs like XPHOZAH into bundled payments for kidney failure, rather than keeping separate payments.
- 3The court must decide if Ardelyx can legally challenge this Medicare rule as it stands.




